Isomorphic Labs Raises $5 Billion for AI Drug Discovery
Isomorphic Labs secured $5 billion in Series C funding from major investors including Alphabet and Sequoia Capital to advance its AI-driven drug discovery platform into clinical trials.
cen · 2026-11-18 00:00